| 19510 |
11-dehydro-2,3-dinor Thromboxane B2
|
|
79250-60-5 |
>98%
|
|
|
|
52.522651933702
|
11-dehydro-2-3-dinor-thromboxane-b2
|
11-dehydro-2,3-dinor TXB2
|
metabolites thromboxanes 11-keto-2,3-dinor-TXB2 11-dehydro-2,3-dinor-TXB2 |
52.522651933702
|
| 19500 |
11-dehydro Thromboxane B2
|
|
67910-12-7 |
≥98%
|
|
|
|
66.848585635359
|
11-dehydro-thromboxane-b2
|
11-keto TXB2; 11-dehydro TXB2
|
metabolites thromboxanes plasma 11-dehydro-TXB2 11-keto-TXB2 atherosclerosis |
66.848585635359
|
| 319500 |
11-dehydro Thromboxane B2-d4
|
|
- |
≥99% deuterated forms (d1-d4)
|
|
|
|
41.575980662983
|
11-dehydro-thromboxane-b2-d4
|
11-keto TXB2-d4
|
GC/MS deuterium isotopes 11-dh-TXB2-d4 internal standards thromboxanes 11-dehydro-TXB2-d4 deuterated GC-MS LC/MS LC-MS mass spectrometry atherosclerosis |
41.575980662983
|
| 519510 |
11-dehydro Thromboxane B2 EIA Kit - Monoclonal
New
|
|
- |
|
|
|
2012-02-08
|
225.763667638633
|
11-dehydro-thromboxane-b2-eia-kit-monoclonal
|
11-dehydro TXB2 ELISA Kit
|
11-dehydro-TXB2 enzymes immunoassays EIAs ELISAs kits assays measures measurements competitive quantification thromboxanes A2 TXA2 arachidonic acids platelets aggregation vascular bronchial smooth muscles hydrolyzed plasma urine ex vivo activation intra-renal production metabolites kidneys metabolized dehydrogenases enzymes cytosolic aldehydes peroxisomes peroxisomal b-oxidations beta-oxidations .beta.-oxidations β-oxidations infusions study studies circulating half-life t1/2 2,3-dinor 11-dehydro-2,3-dinor gas chromatography mass spectrometry GC/MS dosing doses aspirin acetylsalicylic acid NSAIDS nonsteroidal anti-inflammatory drugs smokers levels non-enzymatically 519501 |
225.763667638633
|
| 10007239 |
11-dehydro Thromboxane B2 Lipid Maps MS Standard
|
|
67910-12-7 |
≥98%
|
|
|
2009-01-16
|
20.087947908445
|
11-dehydro-thromboxane-b2-lipid-maps-ms-standard
|
11-dehydro TXB2; 11-keto TXB2
|
metabolites thromboxanes plasma 11-dehydro-TXB2 11-keto-TXB2 atherosclerosis MS mass spectrometry standards |
20.087947908445
|
| 10006831 |
11-dehydro Thromboxane B2 Quant-PAK
|
|
- |
|
|
|
2005-08-08
|
25.818526703499
|
11-dehydro-thromboxane-b2-quant-pak
|
|
Quant-PAKs metabolites thromboxanes plasma deuterium isotopes 11-dh-TXB2-d4 internal standards 11-dehydro-TXB2-d4 deuterated GC/MS GC-MS LC/MS LC-MS mass spectrometry atherosclerosis packs |
25.818526703499
|
| 19995 |
11-dehydro Thromboxane B3
|
|
129228-55-3 |
>98%
|
|
|
|
5.702817679558
|
11-dehydro-thromboxane-b3
|
11-dehydro TXB3
|
metabolites TXA3 thromboxanes 11-dehydro-TXB3 |
5.702817679558
|
| 10008510 |
15(R)-Pinane Thromboxane A2
|
|
- |
>98%
|
|
|
2006-06-14
|
7.662983425415
|
15-r-pinane-thromboxane-a2
|
15(R)-PTA2
|
TXA2 anatagonists TP receptors synthases platelets aggregation analogs inhibits inhibitors inhibition U-46619 cat coronary artery constriction 15-epimer |
7.662983425415
|
| 10006330 |
2,3-dinor Thromboxane B1
|
|
- |
>98%
|
|
|
2005-03-02
|
69.753749013417
|
2-3-dinor-thromboxane-b1
|
2,3-dinor TXB1
|
metabolites thromboxanes urine urinary 2,3-dinor-TXB2 11-dehydro TXB2 biosynthesis humans rats markers rabbits |
69.753749013417
|
| 19050 |
2,3-dinor Thromboxane B2
|
|
63250-09-9 |
≥98%
|
|
|
|
144.739410681399
|
2-3-dinor-thromboxane-b2
|
2,3-dinor TXB2
|
TXA2 dinor metabolites thromboxanes urine urinary 2,3-dinor-TXB2 |
144.739410681399
|
| 519051 |
2,3-dinor Thromboxane B2 EIA Kit
|
|
- |
|
|
|
|
120.509576484096
|
2-3-dinor-thromboxane-b2-eia-kit
|
2,3-dinor Thromboxane B2 ELISA Kit
|
solid plates 2,3-dinor-TXB2 metabolites thromboxanes measures kits eias enzyme atherosclerosis immunoassays ELISAs assays |
120.509576484096
|
| 10007238 |
2,3-dinor Thromboxane B2 Lipid Maps MS Standard
|
|
63250-09-9 |
≥98%
|
|
|
2009-03-15
|
87.748545119705
|
2-3-dinor-thromboxane-b2-lipid-maps-ms-standard
|
2,3-dinor TXB2
|
TXA2 dinor metabolites thromboxanes urine urinary 2,3-dinor-TXB2 MS mass spectrometry standards |
87.748545119705
|
| 19010 |
Carbocyclic Thromboxane A2
|
|
74034-56-3 |
>98%
|
|
|
|
7.788453038674
|
carbocyclic-thromboxane-a2
|
CTA2; Carbocyclic TXA2
|
thromboxanes analogs TXA2 vasoconstriction CTA2 atherosclerosis |
7.788453038674
|
| 19021 |
I-SAP
|
|
133538-58-6 |
≥98%
|
|
|
|
7.417679558011
|
i-sap
|
Iodophenyl sulfonyl amino pinane Thromboxane A2; Iodophenyl sulfonyl amino pinane TXA2
|
thromboxanes ISAP pinane analogs agtagonists TP receptors atherosclerosis |
7.417679558011
|
| 10010971 |
Luminex® 11-dehydro Thromboxane B2 Kit
|
|
- |
|
|
|
2008-01-24
|
43.918881343360
|
luminex-11-dehydro-thromboxane-b2-kit
|
Luminex® 11-dehydro TXB2 Kit
|
thromboxanes thromboxane A2 TXA2 metabolites urine in vivo measures kits luminex xMAP beads assays |
43.918881343360
|
| 19020 |
Pinane Thromboxane A2
|
|
71111-01-8 |
>98%
|
|
|
|
14.260674033149
|
pinane-thromboxane-a2
|
PTA2; Pinane TXA2
|
Thromboxanes analogs TXA2 antagonists TP receptors atherosclerosis |
14.260674033149
|
| 10951 |
Sampling Tubes with Indomethacin
|
|
- |
|
|
|
2011-06-01
|
0E-12
|
sampling-tubes-with-indomethacin
|
|
spi-bio spibio COX inhibitors ex-vivo thromboxane B2 TXB2 PGs prostagandins cyclooxygenase anticoagulant sampling tubes blood metabolites |
0E-12
|
| 19030 |
Thromboxane B2
|
|
54397-85-2 |
≥99%
|
|
|
|
103.580638428483
|
thromboxane-b2
|
TXB2
|
thromboxanes platelets metabolites TXB2 intrarenal TXA2 urine urinary atherosclerosis |
103.580638428483
|
| 319030 |
Thromboxane B2-d4
|
|
- |
≥99% deuterated product
|
|
|
|
44.321860036832
|
thromboxane-b2-d4
|
TXB2-d4
|
GC/MS deuterium isotopes internal standards GC-MS LC/MS LC-MS mass spectrometry atherosclerosis prostaglandins TXB2-d4 thromboxanes deuterated |
44.321860036832
|
| 519031 |
Thromboxane B2 EIA Kit
|
|
- |
|
|
|
|
455.493950327399
|
thromboxane-b2-eia-kit
|
|
solid plates TXB2 thromboxanes measures kits eias enzyme atherosclerosis immunoassays ELISAs assays |
455.493950327399
|
| 10004023 |
Thromboxane B2 Express EIA Kit - Monoclonal
|
|
- |
|
|
|
2004-07-02
|
117.551852993026
|
thromboxane-b2-express-eia-kit-monoclonal
|
TXB2 Express ELISA Kit - Monoclonal; TXB2 Express EIA Kit (Monoclonal)
|
solid plates atherosclerosis thromboxanes measures kits eias enzyme immunoassays ELISAs intrarenal TXA2 synthesis fast same-day assays |
117.551852993026
|
| 10007237 |
Thromboxane B2 Lipid Maps MS Standard
|
|
54397-85-2 |
≥99%
|
|
|
2009-01-16
|
22.881335174954
|
thromboxane-b2-lipid-maps-ms-standard
|
TXB2
|
thromboxanes platelets metabolites TXB2 intrarenal TXA2 urine urinary atherosclerosis MS mass spectrometry standards |
22.881335174954
|
| 10006832 |
Thromboxane B2 Quant-PAK
|
|
- |
|
|
|
2005-08-08
|
26.307495395948
|
thromboxane-b2-quant-pak
|
|
Quant-PAKs thromboxanes platelets metabolites intrarenal TXA2 urine urinary GC/MS deuterium isotopes internal standards GC-MS LC/MS LC-MS mass spectrometry prostaglandins TXB2-d4 deuterated packs |
26.307495395948
|
| 19990 |
Thromboxane B3
|
|
71953-80-5 |
>98%
|
|
|
|
5.702817679558
|
thromboxane-b3
|
TXB3; Δ17-TXB2
|
.DELTA.17-TXB2 Thromboxanes TXB3 TXA3 omega-3 .omega.-3 w-3 d17-TXB2 DELTA17-TXB2 atherosclerosis |
5.702817679558
|
| 10010522 |
U-46619 Glycine methyl ester
|
|
- |
>98%
|
|
|
2008-03-24
|
110.487127071823
|
u-46619-glycine-methyl-ester
|
|
TP receptors agonists inflammations PGH2 endoperoxides thromboxanes vasoconstriction analogs U46619 3 prodrugs forms |
110.487127071823
|